Hepatitis C virus–related factors associated WITH cognitive performance in HIV-HCV-coinfected patients

[1]  N. Ciccarelli,et al.  Liver fibrosis is associated with cognitive impairment in people living with HIV , 2019, Infection.

[2]  V. Vullo,et al.  In vitro effect of antiretroviral drugs on cultured primary astrocytes: analysis of neurotoxicity and matrix metalloproteinase inhibition , 2018, Journal of neurochemistry.

[3]  K. Jordan-Sciutto,et al.  Differential Effects of Antiretroviral Drugs on Neurons In Vitro: Roles for Oxidative Stress and Integrated Stress Response , 2017, Journal of Neuroimmune Pharmacology.

[4]  H. Günthard,et al.  Adverse events of raltegravir and dolutegravir , 2017, AIDS.

[5]  J. Gatell,et al.  Tolerability of integrase inhibitors in a real-life setting , 2017, The Journal of antimicrobial chemotherapy.

[6]  A. Gori,et al.  Brief Report: Peripheral Monocyte/Macrophage Phenotypes Associated With the Evolution of Cognitive Performance in HIV-Infected Patients. , 2017, Journal of acquired immune deficiency syndromes.

[7]  K. Brinkman,et al.  Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practice , 2016, AIDS.

[8]  M. Reale,et al.  Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related. , 2016, AIDS research and human retroviruses.

[9]  A. Srivastava,et al.  Case control study: magnetic resonance spectroscopy of brain in HIV infected patients , 2016, BMC Neurology.

[10]  M. Prosperi,et al.  Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA , 2016, Medicine.

[11]  Mardge H. Cohen,et al.  Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C , 2016, Journal of acquired immune deficiency syndromes.

[12]  Anil Kumar,et al.  Neurotoxicity in the Post-HAART Era: Caution for the Antiretroviral Therapeutics , 2016, Neurotoxicity Research.

[13]  M. Reale,et al.  Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related. , 2016, AIDS research and human retroviruses.

[14]  H. Amièva,et al.  Diabetes and cognitive decline in a French cohort of patients infected with HIV-1 , 2015, Neurology.

[15]  M. Silveri,et al.  Antiretroviral Neuropenetration Scores Better Correlate with Cognitive Performance of HIV-Infected Patients after Accounting for drug Susceptibility , 2015, Antiviral therapy.

[16]  N. Ciccarelli,et al.  Baseline CD4+ T-cell Count and Cardiovascular Risk Factors Predict the Evolution of Cognitive Performance During 2-Year follow-up in HIV-Infected Patients , 2015, Antiviral therapy.

[17]  Fair M. Vassoler,et al.  Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system , 2014, Journal of NeuroVirology.

[18]  M. Silveri,et al.  Comparison of cognitive performance in HIV or HCV mono-infected and HIV–HCV co-infected patients , 2013, Infection.

[19]  M. Silveri,et al.  Cardiovascular risk factors and carotid intima‐media thickness are associated with lower cognitive performance in HIV‐infected patients , 2013, HIV medicine.

[20]  C. Power,et al.  Predictors of symptomatic HIV‐associated neurocognitive disorders in universal health care , 2013, HIV medicine.

[21]  E. Ricci,et al.  Raltegravir central nervous system tolerability in clinical practice: results from a multicenter observational study , 2012, AIDS.

[22]  F. Pereyra,et al.  Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers , 2012, AIDS.

[23]  M. Silveri,et al.  Effect of Aging and Human Immunodeficiency Virus Infection on Cognitive Abilities , 2012, Journal of the American Geriatrics Society.

[24]  S. Newman,et al.  Hepatitis C virus co-infection increases neurocognitive impairment severity and risk of death in treated HIV/AIDS , 2012, Journal of the Neurological Sciences.

[25]  K. Robertson,et al.  Antiretroviral neurotoxicity , 2012, Journal of NeuroVirology.

[26]  S. Letendre.  Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder. , 2011, Topics in antiviral medicine.

[27]  Susan Morgello,et al.  CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy , 2011, AIDS.

[28]  N. Ciccarelli,et al.  Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients , 2011, Neurology.

[29]  Michael Watters,et al.  Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection—The Hawaii Aging with HIV Cohort , 2006, Journal of NeuroVirology.

[30]  Michael J. Taylor,et al.  HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy , 2010, Neurology.

[31]  H. Ehrenreich,et al.  Practice effects in healthy adults: A longitudinal study on frequent repetitive cognitive testing , 2010, BMC Neuroscience.

[32]  D. Clifford,et al.  Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients , 2009, Neurology.

[33]  T. Hassanein,et al.  Cognitive Dysfunction in Chronic Hepatitis C: A Review , 2008, Digestive Diseases and Sciences.

[34]  E. Masliah,et al.  Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. , 2007, The Journal of infectious diseases.

[35]  J. Kaldor,et al.  Cognitive function, mood and health‐related quality of life in hepatitis C virus (HCV)‐monoinfected and HIV/HCV‐coinfected individuals commencing HCV treatment * , 2007, HIV medicine.

[36]  J. Montaner,et al.  Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection , 2006, Hepatology.

[37]  Mardge H. Cohen,et al.  Neuropsychological functioning in a cohort of HIV- and hepatitis C virus-infected women , 2005, AIDS.

[38]  J. Rakela,et al.  Emerging evidence of hepatitis C virus neuroinvasion. , 2005, AIDS.

[39]  C. Hinkin,et al.  Neuropsychological aspects of coinfection with HIV and hepatitis C virus. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  A. Mocroft,et al.  Changing incidence of central nervous system diseases in the EuroSIDA cohort , 2004, Annals of neurology.

[41]  T. Hassanein,et al.  Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C , 2003, Journal of the International Neuropsychological Society.

[42]  R. Chung,et al.  Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  T. Hassanein,et al.  Neuropsychological impairment in patients with chronic hepatitis C , 2002, Hepatology.

[44]  J. Allsop,et al.  Evidence for a cerebral effect of the hepatitis C virus , 2001, The Lancet.